1,508
Participants
Start Date
December 10, 2021
Primary Completion Date
October 12, 2023
Study Completion Date
October 12, 2024
Restrictive oxygen
Lowest oxygen delivery possible (≥21%) ensuring an SpO2 target = 94%
Liberal oxygen
15 L O2/min flow for non-intubated trial participants or FiO2 = 1.0 for intubated trial participants in the initial phase; later in the operating room, intensive care unit, post-anesthesia care unit and ward, the flow/FiO2 can be reduced to ≥12 L O2/min or FiO2 ≥0.6 if the arterial oxygen saturation is ≥98%
Rigshospitalet, Copenhagen University Hospital, Copenhagen
Erasmus MC, University Medical Center Rotterdam, Rotterdam
Inselspital University Hospital Bern, Bern
Odense University Hospital, Odense
Aarhus University Hospital, Aarhus
The Novo Nordic Foundation
OTHER
Rigshospitalet, Denmark
OTHER